Biodegradable membrane for lower eyelid reconstruction: Clinical outcomes and patient satisfaction

Maria Cervatiuc , Igor Vladimirovich Reshetov , Eldor Jonnazarov , Svetlana Vagovna Saakyan
{"title":"Biodegradable membrane for lower eyelid reconstruction: Clinical outcomes and patient satisfaction","authors":"Maria Cervatiuc ,&nbsp;Igor Vladimirovich Reshetov ,&nbsp;Eldor Jonnazarov ,&nbsp;Svetlana Vagovna Saakyan","doi":"10.1016/j.cjprs.2024.10.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Eyelid malignancies often require radical surgical intervention, with a major risk of tissue loss. Reconstructing the eyelid after such procedures is essential to restoring its protective function and aesthetic appearance. Traditional reconstruction methods involve using grafts from other sites of the body; however, these methods are limited by factors such as the availability of donor tissue, potential mismatches in tissue characteristics, and associated complications, including graft failure or scarring. Additionally, donor site morbidity and achieving a perfect match in texture and color remain challenging. Recent advances in biomaterials offer new possibilities for improving surgical outcomes by providing more biocompatible and flexible options that can be tailored to meet patient-specific needs, potentially reducing complications and improving functional and cosmetic outcomes.</div></div><div><h3>Methods</h3><div>The study included 61 patients who underwent lower eyelid reconstruction following the radical removal of malignant tumors. The patients were divided into the experimental (31 patients in whom a biodegradable Diplen membrane was used) and control (30 patients in whom the membrane was not used) groups. Patients were followed up for at least 1 year, with clinical outcomes and patient satisfaction carefully evaluated.</div></div><div><h3>Results</h3><div>The experimental group demonstrated significantly better outcomes regarding eyelid position and color, with fewer complications compared to the control group. Patient satisfaction was significantly higher in the experimental group, demonstrating a strong correlation with clinical outcomes. These findings highlight the effectiveness of the biodegradable Diplen membrane in achieving better functional and aesthetic outcomes.</div></div><div><h3>Conclusions</h3><div>Eyelid reconstruction using the biodegradable Diplen membrane offers excellent functional and aesthetic outcomes, significantly enhancing patient satisfaction, which is crucial for postoperative rehabilitation and improved quality of life.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"6 4","pages":"Pages 172-175"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Plastic and Reconstructive Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2096691124000876","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Eyelid malignancies often require radical surgical intervention, with a major risk of tissue loss. Reconstructing the eyelid after such procedures is essential to restoring its protective function and aesthetic appearance. Traditional reconstruction methods involve using grafts from other sites of the body; however, these methods are limited by factors such as the availability of donor tissue, potential mismatches in tissue characteristics, and associated complications, including graft failure or scarring. Additionally, donor site morbidity and achieving a perfect match in texture and color remain challenging. Recent advances in biomaterials offer new possibilities for improving surgical outcomes by providing more biocompatible and flexible options that can be tailored to meet patient-specific needs, potentially reducing complications and improving functional and cosmetic outcomes.

Methods

The study included 61 patients who underwent lower eyelid reconstruction following the radical removal of malignant tumors. The patients were divided into the experimental (31 patients in whom a biodegradable Diplen membrane was used) and control (30 patients in whom the membrane was not used) groups. Patients were followed up for at least 1 year, with clinical outcomes and patient satisfaction carefully evaluated.

Results

The experimental group demonstrated significantly better outcomes regarding eyelid position and color, with fewer complications compared to the control group. Patient satisfaction was significantly higher in the experimental group, demonstrating a strong correlation with clinical outcomes. These findings highlight the effectiveness of the biodegradable Diplen membrane in achieving better functional and aesthetic outcomes.

Conclusions

Eyelid reconstruction using the biodegradable Diplen membrane offers excellent functional and aesthetic outcomes, significantly enhancing patient satisfaction, which is crucial for postoperative rehabilitation and improved quality of life.
生物可降解膜下眼睑重建:临床结果和患者满意度
背景:眼睑恶性肿瘤通常需要根治性手术干预,主要风险是组织丢失。手术后重建眼睑对于恢复其保护功能和美观是必不可少的。传统的重建方法包括使用身体其他部位的移植物;然而,这些方法受到供体组织的可用性、组织特征的潜在不匹配以及相关并发症(包括移植物失败或疤痕)等因素的限制。此外,供体部位的发病率和实现质地和颜色的完美匹配仍然具有挑战性。生物材料的最新进展为改善手术结果提供了新的可能性,提供了更多的生物相容性和灵活的选择,可以根据患者的具体需求进行定制,潜在地减少并发症,改善功能和美容结果。方法对61例恶性肿瘤根治术后行下眼睑重建术的患者进行研究。将患者分为试验组(31例患者使用可生物降解的Diplen膜)和对照组(30例患者不使用Diplen膜)。患者随访至少1年,仔细评估临床结果和患者满意度。结果与对照组相比,实验组在眼睑位置和颜色方面表现出明显的改善,并发症较少。实验组的患者满意度明显较高,与临床结果有很强的相关性。这些发现强调了生物可降解双双烯膜在实现更好的功能和美学效果方面的有效性。结论生物可降解双plen膜重建眼睑具有良好的功能和美观效果,显著提高了患者满意度,对术后康复和提高生活质量至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chinese Journal of Plastic and Reconstructive Surgery
Chinese Journal of Plastic and Reconstructive Surgery Surgery, Otorhinolaryngology and Facial Plastic Surgery, Pathology and Medical Technology, Transplantation
CiteScore
0.40
自引率
0.00%
发文量
115
审稿时长
55 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信